Literature DB >> 8220421

A gene for familial hemiplegic migraine maps to chromosome 19.

A Joutel1, M G Bousser, V Biousse, P Labauge, H Chabriat, A Nibbio, J Maciazek, B Meyer, M A Bach, J Weissenbach.   

Abstract

Familial hemiplegic migraine is an autosomal dominant disorder of unknown pathogenesis in which the migrainous attacks are marked by the occurrence of a transient hemiplegia during the aura. While investigating CADASIL, mapped previously to chromosome 19, we observed that some patients had recurrent attacks of migraine with aura. Although the clinical and neuroimaging features of familial hemiplegic migraine differ markedly from CADASIL, we hypothesized that the same gene could be involved in the pathogenesis of both conditions. We chose two large pedigrees for linkage analysis of familial hemiplegic migraine. A maximum lod score > 8 was found with two markers that are also strongly linked to CADASIL. Multilocus linkage analysis suggested that the loci responsible for the two diseases reside within an interval of about 30 cM on chromosome 19.

Entities:  

Mesh:

Year:  1993        PMID: 8220421     DOI: 10.1038/ng0993-40

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  56 in total

1.  [Altered cerebral excitability and spreading depression. Causes for the comorbidity of epilepsy and migraine?].

Authors:  T Leniger; H C Diener; A Hufnagel
Journal:  Nervenarzt       Date:  2003-06-18       Impact factor: 1.214

Review 2.  In vivo analysis of voltage-dependent calcium channels.

Authors:  Ling Liu; Theresa A Zwingman; Colin F Fletcher
Journal:  J Bioenerg Biomembr       Date:  2003-12       Impact factor: 2.945

Review 3.  Genetic analysis of voltage-dependent calcium channels.

Authors:  C F Fletcher; N G Copeland; N A Jenkins
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

4.  Assessing the statistical power to detect linkage in a sample of 51 bipolar affective disorder pedigrees.

Authors:  L C Lim; N Craddock; M Owen; P Sham; M M Nöthen; J Körner; M Rietschel; R Fimmer; P Propping; P McGuffin; R Murray; M Gill
Journal:  Behav Genet       Date:  1996-03       Impact factor: 2.805

5.  Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine.

Authors:  A L Jones; R C Roberts; D W Colvin; G L Rubin; M W Coughtrie
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  Searching for migraine genes: exclusion of 290 cM out of the whole human genome.

Authors:  L Monari; M Mochi; M L Valentino; C Arnaldi; P Cortelli; A De Monte; G Pierangeli; G Prologo; C Scapoli; S Soriani; P Montagna
Journal:  Ital J Neurol Sci       Date:  1997-10

7.  Prophylactic Therapy for Migraine.

Authors:  Shazia Afridi; Holger Kaube
Journal:  Curr Treat Options Neurol       Date:  2003-11       Impact factor: 3.598

8.  Localization of a gene for migraine without aura to chromosome 4q21.

Authors:  Asgeir Björnsson; Grétar Gudmundsson; Einar Gudfinnsson; María Hrafnsdóttir; John Benedikz; Svanhildur Skúladóttir; Kristleifur Kristjánsson; Michael L Frigge; Augustine Kong; Kári Stefánsson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2003-09-25       Impact factor: 11.025

Review 9.  Molecular mechanisms of migraine?

Authors:  S V Ramagopalan; N E Ramscar; M Z Cader
Journal:  J Neurol       Date:  2007-11-07       Impact factor: 4.849

Review 10.  A practical guide to the management and prevention of migraine.

Authors:  H C Diener; H Kaube; V Limmroth
Journal:  Drugs       Date:  1998-11       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.